Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRT3983Y in Painful Diabetic Peripheral Neuropathy
NCT01056315Phase 2Terminated
- Sponsor
- Grünenthal GmbH
- Start
- Nov 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GRT3983Y in diabetic neuropathy, sponsored by Grünenthal GmbH. Started Nov 2009; status: terminated.
02
Drugs
GRT3983Y
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01056315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056315.